February 1, 2010 — Changes have been made to the prescribing information for olanzapine (Zyprexa, Eli Lilly) related to its indication for use in adolescents (ages 13 - 17 years) for the treatment of schizophrenia and bipolar I disorder, the US Food and Drug Administration (FDA) announced ...
The benefit of maintaining bipolar I patients on monotherapy with oral ZYPREXA at a dose of 5 to 20 mg/day, afterachieving a responder status for an average duration of 2 weeks, was demonstrated in a controlled trial [seeClinical Studies] . The healthcareprovider who elects to use ZYPREXA ...
In patients with schizophrenia, there was no indication of any different tolerability of olanzapine in the elderly compared to younger patients. Studies in elderly patients with dementia-related psychosis have suggested that there may be a different tolerability profile in this population compared to you...
The benefit of maintaining bipolar I patients on monotherapy with oral ZYPREXA at a dose of 5 to 20 mg/day, afterachieving a responder status for an average duration of 2 weeks, was demonstrated in a controlled trial [seeClinical Studies] . The healthcareprovider who elects to use ZYPREXA ...
[drug for the elderly] There is usually no need to consider using a lower starting dose (5mg/ days), but for older persons over 65 years of age, if there is a clinical indication, a lower start dose should be considered [universal name phonetic alphabet] ZPL [adverse effects] Olanzapine...
In patients with schizophrenia, there was no indication of any different tolerability of olanzapine in the elderly compared to younger patients. Studies in elderly patients with dementia-related psychosis have suggested that there may be a different tolerability profile in this population compared to ...
It was released in the US in November 1996 with FDA approval for that indication. However, antipsychotics have always been used for other psychiatric disorders, aside from schizophrenia. This includes, in particular, mania, where chlorpromazine use predated lithium as an effective treatment. Other ...
Cocaine use disorders represent a substantial clinical and public health burden in many countries, yet there are no well-proven and broadly effective treatments available, and no medication approved for this indication by any national re... DA Gorelick - Springer Milan 被引量: 2发表: 2015年 ...
Although risperidone does not have FDA indication for MDD adjunctive therapy, it was still significantly better than placebo in both treatment response rate and remission rate. Combining all 16 studies, all SGAs significantly outperformed placebo in augmenting antidepressant treatment. The overal...
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstance...